Nighttime awakenings attributed to vasomotor symptoms were significantly reduced within 4 weeks of initiating paroxetine 7.5 mg treatment ( 39 % reduction vs 28 % for placebo ; P = 0.0049 ) , and reductions were sustained through 12 or 24 weeks of treatment .